AFL:NYE-Aflac Incorporated (USD)

COMMON STOCK | Insurance - Life |

Last Closing

USD 103.66

Change

+0.42 (+0.41)%

Market Cap

USD 59.61B

Volume

2.49M

Analyst Target

USD 41.11
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan. The Aflac U.S. segment provides cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, long-term care and disability, and term and whole life insurance products in the United States. It sells its products through sales associates, brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. Aflac Incorporated was founded in 1955 and is headquartered in Columbus, Georgia.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-26 )

Largest Industry Peers for Insurance - Life

Symbol Name Price(Change) Market Cap
MET-PA MetLife Inc Preferred Stock Se..

+0.03 (+0.12%)

USD 48.68B
MET-PE MetLife Inc Preferred Stock Se..

-0.12 (-0.49%)

USD 42.23B
PRU Prudential Financial Inc

+0.81 (+0.68%)

USD 41.94B
PUK Prudential PLC ADR

+0.12 (+0.75%)

USD 22.37B
PRI Primerica Inc

+0.79 (+0.29%)

USD 9.06B
JXN Jackson Financial Inc

+0.35 (+0.39%)

USD 6.76B
FG F&G Annuities & Life Inc.

+0.37 (+0.88%)

USD 5.63B
ANG-PB American National Group Inc

+0.06 (+0.24%)

N/A
ANG-PA American National Group Inc.

+0.10 (+0.40%)

N/A
MET-PF MetLife Inc Preferred Stock Se..

-0.09 (-0.44%)

N/A

ETFs Containing AFL

DIVS SmartETFs Dividend Builde.. 3.11 % 0.00 %

+0.04 (+0.19%)

USD 0.04B
FCSG:LSE FIRST TRUST GLOBAL FUNDS .. 2.33 % 0.00 %

N/A

USD 0.03B
LYLD LYLD 2.30 % 0.00 %

+0.05 (+0.19%)

USD 5.58M
CESG:LSE FIRST TRUST GLOBAL FUNDS .. 2.07 % 0.00 %

N/A

N/A
CORP PIMCO Investment Grade Co.. 0.00 % 0.20 %

+0.08 (+0.19%)

USD 1.24B
CWS AdvisorShares Focused Equ.. 0.00 % 0.68 %

+0.09 (+0.19%)

USD 0.18B
FHF:CA 0.00 % 0.77 %

N/A

N/A
FLI:CA CI U.S. & Canada Lifeco C.. 0.00 % 0.92 %

N/A

CAD 0.09B
FUM:CA 0.00 % 0.80 %

N/A

N/A
IAK iShares U.S. Insurance ET.. 0.00 % 0.43 %

+0.55 (+0.19%)

N/A
IWR iShares Russell Mid-Cap E.. 0.00 % 0.19 %

+0.15 (+0.19%)

USD 39.00B
IWS iShares Russell Mid-Cap V.. 0.00 % 0.24 %

+0.28 (+0.19%)

USD 13.52B
PHE.B:CA 0.00 % 0.97 %

N/A

N/A
QSY 0.00 % 0.38 %

N/A

N/A
CLRG 0.00 % 0.25 %

N/A

N/A
DBX4:F Xtrackers - MSCI EM Europ.. 0.00 % 0.00 %

N/A

N/A
VLIQ:XETRA 0.00 % 0.00 %

N/A

N/A
NSGE:CA NBI Sustainable Global Eq.. 0.00 % 0.00 %

N/A

CAD 0.53B
VDLQ:LSE 0.00 % 0.00 %

N/A

N/A
ADIV SmartETFs Asia Pacific Di.. 0.00 % 0.00 %

+0.05 (+0.19%)

USD 4.73M
FTGS:XETRA FIRST TRUST GLOBAL FUNDS .. 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Insurance - Life) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 25.65% 67% D+ 82% B
Dividend Return 2.42% 38% F 39% F
Total Return 28.07% 61% D- 82% B
Trailing 12 Months  
Capital Gain 26.25% 67% D+ 83% B
Dividend Return 2.44% 38% F 39% F
Total Return 28.68% 67% D+ 84% B
Trailing 5 Years  
Capital Gain 97.00% 73% C 87% B+
Dividend Return 14.67% 42% F 48% F
Total Return 111.67% 73% C 87% B+
Average Annual (5 Year Horizon)  
Capital Gain 21.60% 78% C+ 82% B
Dividend Return 24.26% 78% C+ 82% B
Total Return 2.66% 44% F 59% D-
Risk Return Profile  
Volatility (Standard Deviation) 24.65% 67% D+ 45% F
Risk Adjusted Return 98.43% 94% A 96% N/A
Market Capitalization 59.61B 100% F 96% N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector